Literature DB >> 8663044

Receptor specificity of the fibroblast growth factor family.

D M Ornitz1, J Xu, J S Colvin, D G McEwen, C A MacArthur, F Coulier, G Gao, M Goldfarb.   

Abstract

Fibroblast growth factors (FGFs) are essential molecules for mammalian development. The nine known FGF ligands and the four signaling FGF receptors (and their alternatively spliced variants) are expressed in specific spatial and temporal patterns. The activity of this signaling pathway is regulated by ligand binding specificity, heparan sulfate proteoglycans, and the differential signaling capacity of individual FGF receptors. To determine potentially relevant ligand-receptor pairs we have engineered mitogenically responsive cell lines expressing the major splice variants of all the known FGF receptors. We have assayed the mitogenic activity of the nine known FGF ligands on these cell lines. These studies demonstrate that FGF 1 is the only FGF that can activate all FGF receptor splice variants. Using FGF 1 as an internal standard we have determined the relative activity of all the other members of the FGF family. These data should serve as a biochemical foundation for determining developmental, physiological, and pathophysiological processes that involve FGF signaling pathways.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8663044     DOI: 10.1074/jbc.271.25.15292

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  451 in total

1.  Fgfr2 is required for limb outgrowth and lung-branching morphogenesis.

Authors:  E Arman; R Haffner-Krausz; M Gorivodsky; P Lonai
Journal:  Proc Natl Acad Sci U S A       Date:  1999-10-12       Impact factor: 11.205

2.  Uncoupling fibroblast growth factor receptor 2 ligand binding specificity leads to Apert syndrome-like phenotypes.

Authors:  K Yu; D M Ornitz
Journal:  Proc Natl Acad Sci U S A       Date:  2001-03-27       Impact factor: 11.205

3.  Molecular characteristics of fibroblast growth factor-fibroblast growth factor receptor-heparin-like glycosaminoglycan complex.

Authors:  G Venkataraman; R Raman; V Sasisekharan; R Sasisekharan
Journal:  Proc Natl Acad Sci U S A       Date:  1999-03-30       Impact factor: 11.205

4.  Interrogating protein interaction networks through structural biology.

Authors:  Patrick Aloy; Robert B Russell
Journal:  Proc Natl Acad Sci U S A       Date:  2002-04-23       Impact factor: 11.205

5.  Oligomerization of acidic fibroblast growth factor is not a prerequisite for its cell proliferation activity.

Authors:  Alphonse I Arunkumar; Thallampuranam Krishnaswamy S Kumar; Karuppanan Muthusamy Kathir; Sampath Srisailam; Han-Min Wang; Philominathan Sagaya Theresa Leena; Ya-Hui Chi; Ho-Chz Chen; Chieh-Hsi Wu; Rong-Tsun Wu; Gu-Gang Chang; Ing-Ming Chiu; Chin Yu
Journal:  Protein Sci       Date:  2002-05       Impact factor: 6.725

Review 6.  Epithelial mesenchymal interactions, the ECM and limb development.

Authors:  Peter Lonai
Journal:  J Anat       Date:  2003-01       Impact factor: 2.610

Review 7.  Fibroblast growth factor receptor 3 mutations in achondroplasia and related forms of dwarfism.

Authors:  William A Horton; Gregory P Lunstrum
Journal:  Rev Endocr Metab Disord       Date:  2002-12       Impact factor: 6.514

8.  Four independent mutations in the feline fibroblast growth factor 5 gene determine the long-haired phenotype in domestic cats.

Authors:  James S Kehler; Victor A David; Alejandro A Schäffer; Kristina Bajema; Eduardo Eizirik; David K Ryugo; Steven S Hannah; Stephen J O'Brien; Marilyn Menotti-Raymond
Journal:  J Hered       Date:  2007-09-01       Impact factor: 2.645

9.  Signal transducers and activators of transcription mediate fibroblast growth factor-induced vascular endothelial morphogenesis.

Authors:  Xinhai Yang; Dianhua Qiao; Kristy Meyer; Andreas Friedl
Journal:  Cancer Res       Date:  2009-01-27       Impact factor: 12.701

Review 10.  Shared circuitry: developmental signaling cascades regulate both embryonic and adult coronary vasculature.

Authors:  Kory J Lavine; David M Ornitz
Journal:  Circ Res       Date:  2009-01-30       Impact factor: 17.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.